133 related articles for article (PubMed ID: 19920834)
1. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain.
Marchalant Y; Brothers HM; Wenk GL
Mol Psychiatry; 2009 Dec; 14(12):1068-9. PubMed ID: 19920834
[No Abstract] [Full Text] [Related]
2. New neuron production can be increased in the hippocampus of aged rats following cannabinoid treatment.
Marchalant Y; Brothers HM; Wenk GL
Mol Psychiatry; 2009 Dec; 14(12):1067, 1068-9. PubMed ID: 19920833
[No Abstract] [Full Text] [Related]
3. Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis.
Marchalant Y; Brothers HM; Norman GJ; Karelina K; DeVries AC; Wenk GL
Neurobiol Dis; 2009 May; 34(2):300-7. PubMed ID: 19385063
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
Saez TM; Aronne MP; Caltana L; Brusco AH
J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778
[TBL] [Abstract][Full Text] [Related]
5. Environmental enrichment restores neurogenesis and rapid acquisition in aged rats.
Speisman RB; Kumar A; Rani A; Pastoriza JM; Severance JE; Foster TC; Ormerod BK
Neurobiol Aging; 2013 Jan; 34(1):263-74. PubMed ID: 22795793
[TBL] [Abstract][Full Text] [Related]
6. A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats.
Solbrig MV; Fan Y; Hermanowicz N; Morgese MG; Giuffrida A
Exp Neurol; 2010 Nov; 226(1):231-41. PubMed ID: 20832403
[TBL] [Abstract][Full Text] [Related]
7. Prospects for cannabinoid therapies in viral encephalitis.
Solbrig MV; Fan Y; Hazelton P
Brain Res; 2013 Nov; 1537():273-82. PubMed ID: 24021420
[TBL] [Abstract][Full Text] [Related]
8. Exogenous BDNF increases neurogenesis in the hippocampus in experimental Streptococcus pneumoniae meningitis.
Lian D; He D; Wu J; Liu Y; Zhu M; Sun J; Chen F; Li L
J Neuroimmunol; 2016 May; 294():46-55. PubMed ID: 27138098
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid self-administration in rats: sex differences and the influence of ovarian function.
Fattore L; Spano MS; Altea S; Angius F; Fadda P; Fratta W
Br J Pharmacol; 2007 Nov; 152(5):795-804. PubMed ID: 17891164
[TBL] [Abstract][Full Text] [Related]
10. Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats.
Suenaga T; Ichitani Y
Behav Brain Res; 2008 Jul; 190(2):248-52. PubMed ID: 18374994
[TBL] [Abstract][Full Text] [Related]
11. Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis.
Alén F; Mouret A; Viveros MP; Llorente R; Lepousez G; Lledo PM; López-Moreno JA
Int J Neuropsychopharmacol; 2010 Mar; 13(2):191-205. PubMed ID: 20047713
[TBL] [Abstract][Full Text] [Related]
12. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.
Beinfeld MC; Connolly K
Neurosci Lett; 2001 Mar; 301(1):69-71. PubMed ID: 11239718
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid rescue of striatal progenitor cells in chronic Borna disease viral encephalitis in rats.
Solbrig MV; Hermanowicz N
J Neurovirol; 2008 May; 14(3):252-60. PubMed ID: 18569459
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit.
Ganon-Elazar E; Akirav I
Psychoneuroendocrinology; 2013 Sep; 38(9):1675-87. PubMed ID: 23433741
[TBL] [Abstract][Full Text] [Related]
15. Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2.
Lawston J; Borella A; Robinson JK; Whitaker-Azmitia PM
Brain Res; 2000 Sep; 877(2):407-10. PubMed ID: 10986361
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex.
Oropeza VC; Page ME; Van Bockstaele EJ
Brain Res; 2005 Jun; 1046(1-2):45-54. PubMed ID: 15927549
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
18. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission.
Haller J; Mátyás F; Soproni K; Varga B; Barsy B; Németh B; Mikics E; Freund TF; Hájos N
Eur J Neurosci; 2007 Apr; 25(8):2445-56. PubMed ID: 17445240
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotection by the cannabinoid agonist WIN-55212 in an in vivo newborn rat model of acute severe asphyxia.
Martínez-Orgado J; Fernández-Frutos B; González R; Romero E; Urigüen L; Romero J; Viveros MP
Brain Res Mol Brain Res; 2003 Jun; 114(2):132-9. PubMed ID: 12829323
[TBL] [Abstract][Full Text] [Related]
20. Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions.
Ferraro L; Tomasini MC; Beggiato S; Gaetani S; Cassano T; Cuomo V; Amoroso S; Tanganelli S; Antonelli T
J Neural Transm (Vienna); 2009 Aug; 116(8):1017-27. PubMed ID: 19533296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
